COVID - 19. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: (combination of three drugs Remedsivir, Interferon, and Dexamethasone) Remedsivir drugs with a dose of 200 mg in the initial dose and then 100 mg daily for 5 days,
Sponsors
Yasouj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Definitive diagnosis of covid-19 by infectious disease specialist with a positive PCR and spiral ct scan of the lung. Hospitalized patients who are at least 18 years old.
Exclusion criteria
Exclusion criteria: Pregnant women Patients with GFR less than 30%. Patient with a history of Pancytopenia. Increased ALT more than 10 times.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Arterial oxygen saturation. Timepoint: At the time of admission and discharge of the patient. Method of measurement: pulse oximeter device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Mortality rate. Timepoint: At the end of the intervention and completion of sampling. Method of measurement: By comparing the number of deaths in each group.;Duration of hospitalization. Timepoint: On the day of discharge from the hospital. Method of measurement: Number of hospitalization days. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMoslem Sedaghattalab
Yasouj University of Medical Sciences
Outcome results
None listed